geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes


, : Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes. American Journal of Physiology. Endocrinology and Metabolism 282(1): E38-E45

Hepatic glucose production is increased as a metabolic consequence of insulin resistance in type 2 diabetes. Because fructose 2,6-bisphosphate is an important regulator of hepatic glucose production, we used adenovirus-mediated enzyme overexpression to increase hepatic fructose 2,6-bisphosphate to determine if the hyperglycemia in KK mice, polygenic models of type 2 diabetes, could be ameliorated by reduction of hepatic glucose production. Seven days after treatment with virus encoding a mutant 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase designed to increase fructose 2,6-bisphosphate levels, plasma glucose, lipids, and insulin were significantly reduced in KK/H1J and KK.Cg-A(y)/J mice. Moreover, high fructose 2,6-bisphosphate levels downregulated glucose-6-phosphatase and upregulated glucokinase gene expression, thereby reversing the insulin-resistant pattern of hepatic gene expression of these two key glucose-metabolic enzymes. The increased hepatic fructose 2,6-bisphosphate also reduced adiposity in both KK mice. These results clearly indicate that increasing hepatic fructose 2,6-bisphosphate overcomes the impairment of insulin in suppressing hepatic glucose production, and it provides a potential therapy for type 2 diabetes.

US$29.90

PMID: 11739081


Other references

Yki-Järvinen, H.; Koivisto, V., 1990: Why is there an impaired insulin action in a patient with diabetes?. Duodecim; Laaketieteellinen Aikakauskirja 106(9): 684-693

Wu, F-Yu.; Wu, J-Feng.; Ni, Y-Hsuan., 2014: Long-term outcome after percutaneous endoscopic gastrostomy in children. Percutaneous endoscopic gastrostomy (PEG) is widely accepted as the preferred procedure to establish long-term enteral feeding. To learn the long-term outcomes of the patients who have undergone PEG placement, we reviewed our experience with child...

Yosipovitch, G., 2008: Dry skin and impairment of barrier function associated with itch - new insights. Itch is a common symptom in dry skin related to inflammatory skin diseases, normal aging, and systemic diseases such as chronic renal failure, and HIV. However, correlations between itch and objective measures of barrier function and skin dryness...

Böke, W.; Hübner, H.; Schuur, W., 1974: Failures of prophylactic cryoretinopexy. Modern Problems in Ophthalmology 12(0): 71-73

Becker, D.B.; Schwartz, A.I., 2013: EDIC: a fine accomplishment. Journal of the Massachusetts Dental Society 61(2): 4-5

Limberg, J.K.; Schrage, W.G., 2011: Hypoxia: just say NO?. Journal of Physiology 589(Pt 9): 2111-2112

Gruner, G., 1953: The effect of various udder treatments on the milk and butterfat production of cows. Four groups of 5 cows were used. Washing the udder with warm water (40 degrees C.) and drying before milking increased milk and butterfat yields by 8 and 6% resp. compared with normal let-down procedure; butterfat percentage remained unchanged. Th...

Bassi, M., 1967: Contribution to the knowledge of spontaneous, acquired hernias of the anterolateral abdominal wall. Extrinsic hernia protruding between the muscle fibers of the transverse and small oblique muscles. Minerva Chirurgica 22(21): 1154-1157

Stoffers, J.A., 1979: Energy flow in screened greenhouses. The energy economy of greenhouses was investigated in 2 compartments, one with an aluminized screen, partially open (10%). The reflectivity on the top and bottom sides of the screen is 0.55 and 0.1, and the emittivity 0.33 and 0.78 resp. An artifi...

de Lédinghen, V.; Laforest, C.; Hézode, C.; Pol, S.; Renault, A.; Alric, L.; Larrey, D.; Métivier, S.; Tran, A.; Jézéquel, C.; Samuel, D.; Zoulim, F.; Tual, C.; Pailhé, Aélie.; Gibowski, Séverine.; Bourlière, M.; Bellissant, E.; Pawlotsky, J-Michel., 2017: Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE. Failure to achieve sustained virological response (SVR) with hepatitis C virus (HCV) direct-acting antiviral-based regimens is commonly associated with emergence of resistance-associated substitutions (RAS). Re-treatment of patients who failed pri...